Company Analysis Fujian Wanchen Biotechnology Co., Ltd
1. Summary
Advantages
- Price (29.54 Β₯) is less than fair price (36.73 Β₯)
- The stock's return over the last year (-17.94%) is higher than the sector average (-38.2%).
Disadvantages
- Dividends (0%) are below the sector average (2%).
- The company's current efficiency (ROE=9.02%) is lower than the sector average (ROE=11.47%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Fujian Wanchen Biotechnology Co., Ltd | Consumer Staples | Index | |
|---|---|---|---|
| 7 days | -6.5% | 0% | -1.4% |
| 90 days | 34.5% | -16% | 16.5% |
| 1 year | -17.9% | -38.2% | 39.3% |
300972 vs Sector: Fujian Wanchen Biotechnology Co., Ltd has outperformed the "Consumer Staples" sector by 20.25% over the past year.
300972 vs Market: Fujian Wanchen Biotechnology Co., Ltd has significantly underperformed the market by -57.28% over the past year.
Stable price: 300972 is not significantly more volatile than the rest of the market on "Shenzhen Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 300972 with weekly volatility of -0.3451% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (29.54 Β₯) is lower than the fair price (36.73 Β₯).
Price significantly below the fair price: The current price (29.54 Β₯) is 24.3% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (88.98) is higher than that of the sector as a whole (45.1).
P/E vs Market: The company's P/E (88.98) is higher than that of the market as a whole (63.57).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (9.19) is higher than that of the sector as a whole (3.53).
P/BV vs Market: The company's P/BV (9.19) is higher than that of the market as a whole (3.79).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (5.65) is higher than that of the sector as a whole (3.72).
P/S vs Market: The company's P/S indicator (5.65) is lower than that of the market as a whole (5.87).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (96.2) is higher than that of the sector as a whole (29.03).
EV/Ebitda vs Market: The company's EV/Ebitda (96.2) is higher than that of the market as a whole (25.54).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -4.17% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-4.17%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (0%).
5.4. ROE
ROE vs Sector: The company's ROE (9.02%) is lower than that of the sector as a whole (11.47%).
ROE vs Market: The company's ROE (9.02%) is lower than that of the market as a whole (9.38%).
5.5. ROA
ROA vs Sector: The company's ROA (2.96%) is lower than that of the sector as a whole (5.36%).
ROA vs Market: The company's ROA (2.96%) is lower than that of the market as a whole (3.95%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (0%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '2%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0% has been steadily paid over the past 7 years, DSI=1.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 1 year.
7.3. Payout percentage
Dividend Coverage: Current payments from income (45.21%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
